David Erritzøe
Impact in
- Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
- Clinical Psychology top 0.1%
- Psychedelics and Drug Studies
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 83
- Neuroscience and Neuropharmacology Research 10
-
- Psychedelics and Drug Studies 91
- Co-authors
- Robin Carhart‐HarrisDavid NuttMendel KaelenAmanda FeildingLeor RosemanBruna GiribaldiRosalind WattsGitte M. Knudsen
- Journals
- Journal of Psychopharmacology (17 papers)Scientific Reports (10 papers)NeuroImage (9 papers)Neuropsychopharmacology (8 papers)Frontiers in Psychiatry (6 papers)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
David Erritzøe
133 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Biological Psychiatry 865
- Clinical Psychology 7.1k
- Cellular and Molecular Neuroscience 4.7k
- Organic Chemistry 3.9k
- Toxicology 421
Countries citing papers authored by David Erritzøe
This map shows the geographic impact of David Erritzøe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Erritzøe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Erritzøe more than expected).
Fields of papers citing papers by David Erritzøe
This network shows the impact of papers produced by David Erritzøe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Erritzøe. The network helps show where David Erritzøe may publish in the future.
Co-authors
The 25 scholars most cited alongside David Erritzøe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 17 | |
| 7 | 2024 | 9 | |
| 8 | 2024 | 18 | |
| 9 | 2024 | 11 | |
| 10 | 2024 | 23 | |
| 11 | 2024 | 0 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 17 | |
| 14 | 2023 | 48 | |
| 15 | 2023 | 12 | |
| 16 | 2023 | 20 | |
| 17 | Human brain effects of DMT assessed via EEG-fMRI Hit paper breakdown → | 2023 | 105 |
| 18 | 2022 | 12 | |
| 19 | Increased global integration in the brain after psilocybin therapy for depression Hit paper breakdown → | 2022 | 257 |
| 20 | 2019 | 180 |
About David Erritzøe
David Erritzøe is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology, Biological Psychiatry, Toxicology and Organic Chemistry, having authored 140 papers that have together received 9.7k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (91 papers), Neurotransmitter Receptor Influence on Behavior (83 papers), Chemical synthesis and alkaloids (55 papers), Functional Brain Connectivity Studies (15 papers), Treatment of Major Depression (13 papers), Neuroscience and Neuropharmacology Research (10 papers), Complementary and Alternative Medicine Studies (10 papers) and Forensic Toxicology and Drug Analysis (9 papers). The work is most often cited by research in Biological Psychiatry (865 citations), Clinical Psychology (7.1k citations), Cellular and Molecular Neuroscience (4.7k citations), Organic Chemistry (3.9k citations) and Toxicology (421 citations). David Erritzøe has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Robin Carhart‐Harris, David Nutt, David Nutt, Mendel Kaelen, Amanda Feilding, Robin Carhart‐Harris, Leor Roseman, Bruna Giribaldi, Rosalind Watts and Gitte M. Knudsen. Their work appears in journals such as Journal of Psychopharmacology, Scientific Reports, NeuroImage, Neuropsychopharmacology and Frontiers in Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.